FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry, and more specifically to a new medical use of anemoside B4. Use of anemoside B4 to obtain a medicinal product for the treatment of oral ulcers. Use of anemoside B4 to obtain a medicinal product for the treatment of recurrent ulcers in the oral cavity. Use of anemoside B4 to produce a medicinal product for the treatment of oral ulcers caused by chemotherapy.
EFFECT: above-described use of anemozide reduces the healing time of oral ulcers.
10 cl, 5 tbl, 2 ex
